Determinant of the effectiveness of GLP-1 in type 2 diabetes

被引：0
|
作者：
Toft-Nielsen, MB
Madsbad, S
Damholt, MB
Holst, JJ
机构：
来源：
DIABETES | 2000年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
516
引用
收藏
页码：A127 / A127
页数：1
相关论文
共 50 条
  • [41] An overview of new GLP-1 receptor agonists for type 2 diabetes
    Tomlinson, Brian
    Hu, Miao
    Zhang, Yuzhen
    Chan, Paul
    Liu, Zhong-Min
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (02) : 145 - 158
  • [42] RESISTANCE TO THE GLP-1 EFFECTS ON PLATELETS IN TYPE 2 DIABETES MELLITUS
    Barale, C.
    Cavalot, F.
    Mattiello, L.
    Guerrasio, A.
    Russo, I
    JOURNAL OF VASCULAR RESEARCH, 2015, 52 : 50 - 50
  • [43] GLP-1 Receptor as a Biomarker for Incretin Function in Type 2 Diabetes
    Rajan, Sindhu
    Ancsin, John B.
    Mathew, Elizabeth
    Janardanan, Jyothi
    Philipson, Louis
    DIABETES, 2013, 62 : A473 - A473
  • [44] Addition of a GLP-1 Agonist to Insulin Therapy in Type 2 Diabetes
    Gavigan, Colleen
    Donner, Thomas W.
    DIABETES, 2021, 70
  • [45] GLP-1 and type 2 diabetes: physiology and new clinical advances
    Combettes, Murielle M. J.
    CURRENT OPINION IN PHARMACOLOGY, 2006, 6 (06) : 598 - 605
  • [46] GLP-1 as a Therapeutic Agent in Patients with Type 2 Diabetes Mellitus
    Legakis, Ioannis
    RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY, 2007, 1 (03) : 193 - 201
  • [47] The combination of insulin and GLP-1 analogues in the treatment of type 2 diabetes
    van der Klauw, M. M.
    Wolffenbuttel, B. H. R.
    NETHERLANDS JOURNAL OF MEDICINE, 2012, 70 (10): : 436 - 443
  • [48] Reduced Release of GLP-1 in Subgroups of Prediabetes and Type 2 Diabetes
    Faerch, Kristine
    Torekov, Signe S.
    Johansen, Nanna B.
    Witte, Daniel R.
    Jonsson, Anna E.
    Pedersen, Oluf
    Hansen, Torben
    Lauritzen, Torsten
    Sandbaek, Annelli
    Holst, Jens J.
    Vistisen, Dorte
    Jorgensen, Marit E.
    DIABETES, 2014, 63 : A452 - A452
  • [49] GLP-1 RA and Risk of Malignancy in Patients with Type 2 Diabetes
    Ishola, Faidat A.
    Pike, C. William
    Kim, Sun H.
    DIABETES, 2024, 73
  • [50] GLP-1 receptor agonists and basal insulin in type 2 diabetes
    Young, Laura A.
    Buse, John B.
    LANCET, 2014, 384 (9961): : 2180 - 2181
12345